{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:00:19Z","timestamp":1777633219857,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["BIC\/11(02)\/2015"],"award-info":[{"award-number":["BIC\/11(02)\/2015"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.biopha.2017.05.085","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T01:46:48Z","timestamp":1496540808000},"page":"720-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals"],"prefix":"10.1016","volume":"92","author":[{"given":"Tanveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neetu","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anureet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Yugraj","family":"Gawande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh Kumar","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.05.085_bib0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0015","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2015.07.027","article-title":"Adverse cognitive effects of antiepileptic pharmacotherapy: each additional drug matters","volume":"25","author":"Witt","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yebeh.2008.05.006","article-title":"The safety and tolerability of galantamine in patients with epilepsy and memory difficulties","volume":"13","author":"Griffith","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends in Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2017.05.085_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3892\/etm.2014.1711","article-title":"High dosage of agmatine alleviates pentylenetetrazole-induced chronic seizures in rats possibly by exerting an anticonvulsive effect","volume":"8","author":"Xu","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2017.05.085_bib0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yebeh.2010.04.014","article-title":"Agmatine enhances the anticonvulsant effect of lithium chloride on pentylenetetrazole-induced seizures in mice: involvement of L-arginine\/nitric oxide pathway","volume":"18","author":"Bahremand","year":"2010","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2011.05.043","article-title":"Additive anticonvulsant effects of agmatine and lithium chloride on pentylenetetrazole-induced clonic seizure in mice: involvement of \u03b12-adrenoceptor","volume":"666","author":"Bahremand","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.yebeh.2011.07.002","article-title":"The interaction of melatonin and agmatine on pentylenetetrazole-induced seizure threshold in mice","volume":"22","author":"Moezi","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.physbeh.2013.05.022","article-title":"Role of nitric oxide in additive anticonvulsant effects of agmatine and morphine","volume":"118","author":"Payandemehr","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2005.08.008","article-title":"Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects","volume":"390","author":"Feng","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.05.085_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pbb.2003.11.016","article-title":"Anticonvulsive effect of agmatine in mice","volume":"77","author":"Su","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-11-41","article-title":"Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy","volume":"11","author":"Xie","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.biopha.2017.05.085_bib0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-014-0151-1","article-title":"The common inflammatory etiology of depression and cognitive impairment: a therapeutic target","volume":"11","author":"Allison","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.biopha.2017.05.085_bib0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pnpbp.2013.12.012","article-title":"Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice","volume":"50","author":"Freitas","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2017.05.085_bib0080","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.euroneuro.2016.10.013","article-title":"Agmatine, a potential novel therapeutic strategy for depression","volume":"26","author":"Freitas","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0085","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","article-title":"Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice","volume":"53","author":"Freitas","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharep.2016.10.001","article-title":"Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression","volume":"69","author":"Singh","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2017.05.085_bib0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yebeh.2016.05.005","article-title":"Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression","volume":"61","author":"Singh","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2016.05.019","article-title":"Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression","volume":"784","author":"Singh","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2017.05.085_bib0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yebeh.2012.11.004","article-title":"Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice","volume":"27","author":"Singh","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0115","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s11064-013-1163-4","article-title":"Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy","volume":"38","author":"Mishra","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2017.05.085_bib0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.yebeh.2013.05.002","article-title":"Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures","volume":"28","author":"Russo","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0125","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s11064-016-2001-2","article-title":"Protective effect of nerolidol against pentylenetetrazol-induced kindling, oxidative stress and associated behavioral comorbidities in mice","volume":"41","author":"Kaur","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2017.05.085_bib0130","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/jcbfm.2013.54","article-title":"Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice","volume":"33","author":"Smeland","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.biopha.2017.05.085_bib0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(03)15166-5","article-title":"Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy","volume":"363","author":"Eid","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.05.085_bib0140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.WNL.0000149636.44660.99","article-title":"Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy","volume":"64","author":"Van Der Hel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2017.05.085_bib0145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.eplepsyres.2011.02.003","article-title":"Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy","volume":"94","author":"Liimatainen","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.biopha.2017.05.085_bib0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-011-0700-z","article-title":"The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures","volume":"119","author":"Szyndler","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.biopha.2017.05.085_bib0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(84)90509-9","article-title":"Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children","volume":"2","author":"L\u00f6scher","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.05.085_bib0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yebeh.2016.10.007","article-title":"Managing epilepsy-associated depression: serotonin enhancers or serotonin producers","volume":"66","author":"Singh","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2017.05.085_bib0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9441-0","article-title":"Valproate disturbs the balance between branched and aromatic amino acids in rats","volume":"25","author":"Maciejak","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2017.05.085_bib0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2005.08.008","article-title":"Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects","volume":"390","author":"Feng","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.05.085_bib0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(00)00282-3","article-title":"Role of nitric oxide in the regulation of monoaminergic neurotransmission","volume":"52","author":"Kiss","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2017.05.085_bib0180","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0028-3908(03)00199-0","article-title":"Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide","volume":"45","author":"Demehri","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.05.085_bib0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2015.11.044","article-title":"Involvement of nitric oxide in anticompulsive-like effect of agmatine on marble-burying behaviour in mice","volume":"770","author":"Gawali","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.085_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.07.004","article-title":"Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators","volume":"149","author":"Gawali","year":"2016","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217311630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217311630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:44:17Z","timestamp":1772264657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217311630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":38,"alternative-id":["S0753332217311630"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.085","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}